11 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketones.

Marion Merrell Dow Research Institute
A new class of high affinity ligands for the neurokinin A NK2 receptor: psi (CH2NR) reduced peptide bond analogues of neurokinin A4-10.

Marion Merrell Dow Research Institute
Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11.

Marion Merrell Dow Research Institute
Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.

Marion Merrell Dow Research Institute
Multisubstrate inhibition of 4-hydroxybenzoate 3-monooxygenase.

Marion Merrell Dow Research Institute
Design, synthesis, and conformational analysis of a novel macrocyclic HIV-protease inhibitor.

Marion Merrell Dow Research Institute
Inhibition of human neutrophil elastase. 3. An orally active enol acetate prodrug.

Marion Merrell Dow Research Institute
Novel time-dependent inhibitors of human placental aromatase.

Marion Merrell Dow Research Institute
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.

Marion Merrell Dow Research Institute
Conformationally restrained, chiral (phenylisopropyl)amino-substituted pyrazolo[3,4-d]pyrimidines and purines with selectivity for adenosine A1 and A2 receptors.

Marion Merrell Dow Research Institute
N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase.

Marion Merrell Dow Research Institute